Oxytosis: A novel form of programmed cell death

Author(s): Tan S, Schubert D, Maher P

Abstract

Extensive nerve cell death occurs during the development of the central nervous system as well as in episodes of trauma and in neurodegenerative disease. The mechanistic details of how these cells die are poorly understood. Here we describe a unique oxidative stress-induced programmed cell death pathway called oxytosis, and outline pharmacological approaches which interfere with its execution. Oxidative glutamate toxicity, in which exogenous glutamate inhibits cystine uptake through the cystine/glutamate antiporter leading to a depletion of glutathione, is used as an example of oxytosis. It is shown that there is a sequential requirement for de novo macromolecular synthesis, lipoxygenase activation, reactive oxygen species production, and the opening of cGMP-gated channels which allow the influx of extracellular calcium. The translation initiation factor elF2alpha plays a central role in this pathway by regulating the levels of glutathione. Finally, examples are given in which the reduction in glutathione, the production of reactive oxygen species, and calcium influx can be experimentally manipulated to prevent cell death. Data are reviewed which suggest that oxytosis may be involved in nerve cell death associated with nervous system trauma and disease.

Similar Articles

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry

Author(s): Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, et al.

Thrombolytic therapy for ischemic stroke--a review

Author(s): Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, et al.

Thrombolytic therapy for ischemic stroke--a review

Author(s): Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, et al.

Newer thrombolytic agents

Author(s): Verstraete M

Thrombolysis with alteplase 3 to 4

Author(s): Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, et al.

A broadly neuroprotective derivative of curcumin

Author(s): Liu Y, Dargusch R, Maher P, Schubert D

Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease

Author(s): Valera E, Dargusch R, Maher PA, Schubert D

Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance

Author(s): Panzhinskiy E, Hua Y, Lapchak PA, Topchiy E, Lehmann TE, et al.

Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling

Author(s): Narumoto O, Matsuo Y, Sakaguchi M, Shoji S, Yamashita N, et al.

Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke

Author(s): Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, et al.

The science of stroke: mechanisms in search of treatments

Author(s): Moskowitz MA, Lo EH, Iadecola C

A broadly neuroprotective derivative of curcumin

Author(s): Liu Y, Dargusch R, Maher P, Schubert D

2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo

Author(s): Liot G, Benchenane K, Léveillé F, López-Atalaya JP, Fernández-Monreal M, et al.

Acceleration of thrombolysis with ultrasound through the cranium in a flow model

Author(s): Spengos K, Behrens S, Daffertshofer M, Dempfle CE, Hennerici M

A call for transparent reporting to optimize the predictive value of preclinical research

Author(s): Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, et al.